The [FURL=https://www.industryarc.com/Research/Male-Infertility-Market-Research-508533?utm_source=Briefingwire&utm_medium=Pressrelease&utm_campaign=PaidPressrelease]Male Infertility Market[/FURL] size was estimated at $3.18 billion in 2020, projected to grow at a CAGR of 4.8% during the forecast period 2021-2026. Male infertility is a condition that is characterized by the failure of a man's reproductive system to achieve a pregnancy after a period of 12 months or more of unprotected activity. Millions of people of reproductive age around the world are affected by infertility, which also has an impact on their families and societies. Infertility affects 48 million couples and 186 million people worldwide, according to WHO estimates. Infertility in men is most often caused by problems with sperm ejection, sperm absence or low amounts, or sperm that have abnormal morphology and movement (motility). Assisted Reproductive Technologies address a broad range of infertility therapies that provide options for males with issues like low sperm count, poor sperm content, and poor motility. Furthermore, as opposed to drugs, Assisted Reproductive Technologies to have a high success rate owing to advances in these technologies as a result the demand for male infertility is expected to expand significantly in the future.Key Takeaways
Geographically, The Europe region held 31.3% of the total market share in 2020 owing to the availability of well-equipped and specialized fertility clinics and increasing acceptance of expensive treatment options.
Increase in the prevalence of infertility diseases that demand assisted reproductive technology treatment and surgical procedures is the major driving force for the Male Infertility Market during the forecast period 2021-2026.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Male Infertility Market.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508533[/FURL]
Male Infertility Market Segment Analysis - By Geography
Based on geography, Europe dominated the Male Infertility Market with a regional share of 31.3% in 2020 followed by North America and APAC. The rising geriatric population, diseases, and increasing acceptance of minimally invasive procedures are the major factors driving the growth in this region. Moreover, the presence of a large number of advance and well-equipped specialized fertility clinics and manufacturing companies that invest heavily in R&D is further predicted to propel the market growth in this region.
Male Infertility Market Driver
Increasing incidence of Disease
Male Infertility Market top 10 companies are Halotech DNA, Bayer AG, EMD Serono Inc., Endo International plc, Vitrolife, Theramex, Aytu BioScience, Sandstone Diagnostics, Inc., Cadila Healthcare Ltd., and CinnaGen Co.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.